Related Experiment Video
Updated: Aug 21, 2026
Analyzing Mitochondrial Function in a Drosophila melanogaster PINK1B9-Null Mutant Using High-resolution Respirometry
Published on: November 10, 2023
Ringer Loss in Drosophila Uncovers Mitochondrial Complex I Deficits Relevant to Human Parkinson's Disease
Abstract:
Tubulin polymerization promoting proteins (TPPPs) are known for their cytoskeletal regulation across species; however, emerging evidence suggests broader cellular functions, including potential roles in mitochondrial biology. Here, we identify the Drosophila homolog of human TPPP, Ringer, as a previously unrecognized regulator of mitochondrial bioenergetics and electron transport chain Complex I (CI) function. Ringer is enriched in the mitochondrial matrix, and its loss results in reduced levels of multiple CI subunits and assembly factors and a significant decrease in CI enzymatic activity. Notably, in addition to TPPP dysfunction, similar deficits are observed in postmortem human Parkinson's disease (PD) brain tissues, underscoring the translational relevance of our Drosophila model. Pharmacological administration of resveratrol, a reactive oxygen species (ROS) scavenger, reduces mitochondrial superoxide levels and improves CI enzymatic activity and ATP production in ringer mutants, demonstrating that targeted antioxidant therapeutics can improve bioenergetic functions in ringer mutants. Together, these findings establish Ringer as a key regulator of mitochondrial bioenergetics and reveal Ringer-induced CI dysfunction as a phenotype relevant to mitochondrial abnormalities observed in PD, and provide a robust and translationally meaningful framework for investigating mitochondrial dysfunction in PD.
Insights
The study identifies Ringer, a tubulin polymerization promoting protein (TPPP), as crucial for mitochondrial energy production and electron transport chain complex I (CI) function. Loss of Ringer impairs CI, mirroring Parkinson's disease (PD) deficits, but resveratrol treatment shows promise.
Area of Science:
- Mitochondrial biology
- Cellular bioenergetics
- Neurodegenerative disease mechanisms
Background:
- Tubulin polymerization promoting proteins (TPPPs) primarily regulate cytoskeletal dynamics.
- Emerging research suggests TPPPs have diverse cellular roles beyond the cytoskeleton.
- Mitochondrial dysfunction is increasingly implicated in neurodegenerative disorders like Parkinson's disease (PD).
Purpose of the Study:
- To investigate the role of the Drosophila TPPP homolog, Ringer, in mitochondrial function.
- To explore the link between Ringer, mitochondrial bioenergetics, and electron transport chain complex I (CI) activity.
- To assess the translational relevance of Ringer's function in the context of Parkinson's disease.
Main Methods:
- Identification and characterization of the Drosophila TPPP homolog, Ringer.
- Analysis of Ringer's localization within mitochondria.
- Assessment of mitochondrial electron transport chain complex I (CI) subunit levels, assembly factors, and enzymatic activity in Ringer mutants.
- Comparison of findings with postmortem human Parkinson's disease brain tissues.
- Evaluation of the therapeutic potential of resveratrol in ameliorating mitochondrial deficits in Ringer mutants.
Main Results:
- Ringer is localized to the mitochondrial matrix.
- Ringer deficiency leads to reduced CI subunits, assembly factors, and enzymatic activity.
- Mitochondrial deficits in Ringer mutants resemble those observed in human Parkinson's disease brain tissue.
- Resveratrol treatment improved CI activity, ATP production, and reduced reactive oxygen species (ROS) in Ringer mutants.
Conclusions:
- Ringer is a novel regulator of mitochondrial bioenergetics and CI function.
- CI instability due to Ringer loss represents a potential mechanism in Parkinson's disease-associated mitochondrial dysfunction.
- Targeted antioxidant therapies, like resveratrol, show therapeutic potential for mitochondrial dysfunction linked to Ringer loss.
Related Concept Videos
01:24Parkinson Disease ll: Pathophysiology
01:24Parkinson Disease l: Introduction